Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.

Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J, Atkins H, Allan D, Dilworth FJ, Gentleman R, Tapscott SJ, Brand M.

EMBO J. 2011 Feb 2;30(3):494-509. doi: 10.1038/emboj.2010.342. Epub 2010 Dec 21.

2.

A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.

Draheim KM, Hermance N, Yang Y, Arous E, Calvo J, Kelliher MA.

Oncogene. 2011 Mar 10;30(10):1252-60. doi: 10.1038/onc.2010.495. Epub 2010 Nov 8.

3.

Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis.

Wu W, Morrissey CS, Keller CA, Mishra T, Pimkin M, Blobel GA, Weiss MJ, Hardison RC.

Genome Res. 2014 Dec;24(12):1945-62. doi: 10.1101/gr.164830.113. Epub 2014 Oct 15.

4.

Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Palomero T, Odom DT, O'Neil J, Ferrando AA, Margolin A, Neuberg DS, Winter SS, Larson RS, Li W, Liu XS, Young RA, Look AT.

Blood. 2006 Aug 1;108(3):986-92. Epub 2006 Apr 18.

5.

Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.

Landry JR, Kinston S, Knezevic K, de Bruijn MF, Wilson N, Nottingham WT, Peitz M, Edenhofer F, Pimanda JE, Ottersbach K, Göttgens B.

Blood. 2008 Mar 15;111(6):3005-14. doi: 10.1182/blood-2007-07-098830. Epub 2008 Jan 9.

6.

Tal1/SCL binding to pericentromeric DNA represses transcription.

Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT.

J Biol Chem. 2005 Apr 1;280(13):12956-66. Epub 2005 Jan 27.

7.

Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, Green AL, Vyas P, Porcher C.

Genome Res. 2010 Aug;20(8):1064-83. doi: 10.1101/gr.104935.110. Epub 2010 Jun 21.

8.

Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.

Patel B, Kang Y, Cui K, Litt M, Riberio MS, Deng C, Salz T, Casada S, Fu X, Qiu Y, Zhao K, Huang S.

Leukemia. 2014 Feb;28(2):349-61. doi: 10.1038/leu.2013.158. Epub 2013 May 23.

PMID:
23698277
9.

Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.

Zhou RQ, Wu JH, Gong YP, Guo Y, Xing HY.

Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):39-46. doi: 10.1016/j.bcmd.2013.12.007. Epub 2014 Jan 7.

PMID:
24405580
10.

The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.

Robb L, Begley CG.

Bioessays. 1997 Jul;19(7):607-13. Review.

PMID:
9230693
11.

Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.

Terme JM, Mocquet V, Kuhlmann AS, Zane L, Mortreux F, Wattel E, Duc Dodon M, Jalinot P.

Leukemia. 2009 Nov;23(11):2081-9. doi: 10.1038/leu.2009.131. Epub 2009 Jul 9.

PMID:
19587703
12.

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.

Gering M, Yamada Y, Rabbitts TH, Patient RK.

Development. 2003 Dec;130(25):6187-99. Epub 2003 Nov 5.

13.

RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.

Kuvardina ON, Herglotz J, Kolodziej S, Kohrs N, Herkt S, Wojcik B, Oellerich T, Corso J, Behrens K, Kumar A, Hussong H, Urlaub H, Koch J, Serve H, Bonig H, Stocking C, Rieger MA, Lausen J.

Blood. 2015 Jun 4;125(23):3570-9. doi: 10.1182/blood-2014-11-610519. Epub 2015 Apr 24.

14.

SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.

Hoang T, Lambert JA, Martin R.

Curr Top Dev Biol. 2016;118:163-204. doi: 10.1016/bs.ctdb.2016.01.004. Epub 2016 Feb 18. Review.

PMID:
27137657
15.

Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.

Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C.

Blood. 1995 Jul 1;86(1):164-75.

16.

T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Rogers H, Wang L, Yu X, Alnaeeli M, Cui K, Zhao K, Bieker JJ, Prchal J, Huang S, Weksler B, Noguchi CT.

J Biol Chem. 2012 Oct 26;287(44):36720-31. doi: 10.1074/jbc.M112.378398. Epub 2012 Sep 16.

17.

Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.

Talora C, Cialfi S, Oliviero C, Palermo R, Pascucci M, Frati L, Vacca A, Gulino A, Screpanti I.

Blood. 2006 Apr 15;107(8):3313-20. Epub 2005 Dec 20.

18.

Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.

Nie L, Wu H, Sun XH.

J Biol Chem. 2008 Jan 11;283(2):684-92. Epub 2007 Oct 25.

19.

The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.

Dey S, Curtis DJ, Jane SM, Brandt SJ.

Mol Cell Biol. 2010 May;30(9):2181-92. doi: 10.1128/MCB.01441-09. Epub 2010 Mar 1.

20.

Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.

Pimkin M, Kossenkov AV, Mishra T, Morrissey CS, Wu W, Keller CA, Blobel GA, Lee D, Beer MA, Hardison RC, Weiss MJ.

Genome Res. 2014 Dec;24(12):1932-44. doi: 10.1101/gr.164178.113. Epub 2014 Oct 15.

Supplemental Content

Support Center